They also include (1) individuals with familial pancreatic cancer (FPC) kindreds (see Canto et al. (2013) [12] for a full definition of FPC), (2) individuals with germline mutations in ATM, BRCA1, BRCA2, CDKN2A, PALB2, PRSS1, STK11, and TP53, (3) individuals with Lynch syndrome, and (4) individuals with Peutz–Jeghers syndrome (PJS) [9,10,12]. The gene discussed is CDKN2A; the disease is Lynch syndrome.